Sutent fails breast cancer trial

[News]

Drugmaker Pfizer has stopped a late-stage trial on the drug Sutent because it was not proving effective for patients with advanced breast cancer.

More... (http://www.healthcentral.com/breast-cancer/news-287061-98.html)